NINOSKA GUTIERREZ: Open Payments
NPI 1053757740 · BRUNSWICK, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$747 in 38 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $74 · 2025 $747
Food & beverage: $747
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $224 |
| Ardelyx, Inc. | 4 | $82 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $71 |
| Janssen Biotech, Inc. | 3 | $64 |
| Gilead Sciences, Inc. | 2 | $61 |
| Regeneron Healthcare Solutions, Inc. | 2 | $51 |
| QOL Medical, LLC | 1 | $40 |
| Aimmune Therapeutics, Inc. | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| Lilly USA, LLC | 1 | $26 |
Products named: RINVOQ, IBSRELA, XIFAXAN, TREMFYA, CREON, SKYRIZI, DUPIXENT, Sucraid.
Industry payments across GA — which companies pay providers there.
